VOENA, Claudia
 Distribuzione geografica
Continente #
NA - Nord America 2.583
EU - Europa 1.714
AS - Asia 716
AF - Africa 27
OC - Oceania 8
SA - Sud America 5
Continente sconosciuto - Info sul continente non disponibili 1
Totale 5.054
Nazione #
US - Stati Uniti d'America 2.553
CN - Cina 490
IT - Italia 360
SE - Svezia 231
IE - Irlanda 216
UA - Ucraina 149
DK - Danimarca 144
FR - Francia 132
DE - Germania 120
FI - Finlandia 99
AT - Austria 72
KR - Corea 67
BE - Belgio 54
GB - Regno Unito 47
IN - India 38
PL - Polonia 37
JP - Giappone 35
VN - Vietnam 35
CA - Canada 28
SN - Senegal 24
ES - Italia 16
TR - Turchia 12
HK - Hong Kong 10
RU - Federazione Russa 9
AU - Australia 8
TW - Taiwan 8
RO - Romania 6
NL - Olanda 5
PT - Portogallo 4
SG - Singapore 4
BR - Brasile 2
BY - Bielorussia 2
CH - Svizzera 2
CZ - Repubblica Ceca 2
GR - Grecia 2
ID - Indonesia 2
LT - Lituania 2
MX - Messico 2
MY - Malesia 2
NG - Nigeria 2
NO - Norvegia 2
PE - Perù 2
SA - Arabia Saudita 2
TH - Thailandia 2
UZ - Uzbekistan 2
AM - Armenia 1
AR - Argentina 1
EG - Egitto 1
EU - Europa 1
IL - Israele 1
KW - Kuwait 1
KZ - Kazakistan 1
LU - Lussemburgo 1
MO - Macao, regione amministrativa speciale della Cina 1
PH - Filippine 1
PK - Pakistan 1
Totale 5.054
Città #
Chandler 399
Beijing 315
Dublin 216
Ann Arbor 215
Houston 149
Fairfield 148
Torino 138
Ashburn 132
Wilmington 103
Jacksonville 102
Villeurbanne 89
Nyköping 85
Medford 72
Vienna 71
Woodbridge 71
Princeton 62
Dearborn 61
Cambridge 58
Seattle 58
Brussels 49
Fremont 45
Pisa 38
Turin 33
Warsaw 32
Shanghai 28
Boston 25
San Mateo 24
Pune 23
Dong Ket 21
Redwood City 21
Norwalk 19
Milan 16
Boardman 15
Guangzhou 15
Nanjing 13
Tokyo 13
Chengdu 11
Hangzhou 11
Grafing 10
Rome 10
San Diego 10
Jülich 9
Toronto 9
Washington 9
New York 8
Duncan 7
Bologna 6
Hefei 6
Ottawa 6
Verona 6
Central 5
Düsseldorf 5
El Paso 5
Falls Church 5
Jinan 5
Lissone 5
Occimiano 5
Taipei 5
Tappahannock 5
Wuhan 5
Baotou 4
Changsha 4
Hebei 4
Kunming 4
Lachine 4
Lanzhou 4
Mountain View 4
Munich 4
Nanchang 4
Palermo 4
Philadelphia 4
Phoenix 4
Raritan 4
Upper Marlboro 4
Valdagno 4
Zhengzhou 4
Ahmedabad 3
Aurora 3
Berlin 3
Buffalo 3
Chongqing 3
Genoa 3
Göttingen 3
Helsinki 3
Hull 3
Liverpool 3
Montréal 3
New Haven 3
Saint Petersburg 3
San Jose 3
Santa Monica 3
Silver Spring 3
Trieste 3
Valencia 3
Varese 3
Walhain 3
Xian 3
Amsterdam 2
Antalya 2
Bochum 2
Totale 3.275
Nome #
A theranostic approach based on the use of a dual boron/Gd agent to improve the efficacy of Boron Neutron Capture Therapy in the lung cancer treatment 366
Phosphatidylinositol 3-kinase δ blockade increases genomic instability in B cells 363
p130Cas mediates the transforming properties of the anaplastic lymphoma kinase 241
Excess of NPM-ALK oncogenic signaling promotes cellular apoptosis and drug dependency 235
The anaplastic lymphoma kinase controls cell shape and growth of anaplastic large cell lymphoma through Cdc42 activation 227
Efficacy of a Cancer Vaccine against ALK-Rearranged Lung Tumors 204
Redundant and non-redundant roles for Cdc42 and Rac1 in lymphomas developed in NPM-ALK transgenic mice 181
Maternal immunization: New perspectives on its application against non-infectious related diseases in newborns 132
The EGFR family members sustain the neoplastic phenotype of ALK+ lung adenocarcinoma via EGR1. 119
Anaplastic lymphoma kinase in human cancer 116
The enzymatic activity of 5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase is enhanced by NPM-ALK: new insights in ALK-mediated pathogenesis and the treatment of ALCL 108
Oncogenic ALK regulates EMT in non-small cell lung carcinoma through repression of the epithelial splicing regulatory protein 1 103
Evidence for a bone marrow B cell transcribing malignant plasma cell VDJ joined to C mu sequence in immunoglobulin IgG and IgA secreting multiple myelomas 101
Idiotype vaccination in human myeloma: generation of tumor-specific immune responses after high-dose chemotherapy. 99
Involvement of Grb2 adaptor protein in nucleophosmin-anaplastic lymphoma kinase (NPM-ALK)-mediated signaling and anaplastic large cell lymphoma growth. 98
Wiskott–Aldrich syndrome protein (WASP) is a tumor suppressor in T cell lymphoma 98
Detection of circulating tumor cells in multiple myeloma by a PCR-based method. 93
BRAF gene is not mutated in plasma cell leukemia and multiple myeloma 86
A novel nested-PCR strategy for the detection of rearranged immunoglobulin heavy-chain genes in B cell tumors. 84
RhoA silencing reverts the resistance to doxorubicin in human colon cancer cells 83
ALK-dependent control of hypoxia-inducible factors mediates tumor growth and metastasis 82
The mutation of N-ras oncogene does not involve myeloid and erythroid lineages in a case of multiple myeloma. 80
Detection of minimal residual disease by real-time PCR can be used as a surrogate marker to evaluate the graft-versus-myeloma effect after allogeneic stem cell transplantation. 77
Molecular monitoring of minimal residual disease in follicular and mantle cell non-Hodgkin's lymphomas treated with high-dose chemotherapy and peripheral blood progenitor cell autografting. 76
Clinical and molecular remission after allogeneic blood cell transplantation in a patient with mantle-cell lymphoma. 75
NPM-ALK oncogenic tyrosine kinase controls T-cell identity by transcriptional regulation and epigenetic silencing in lymphoma cells 72
Molecular purging of multiple myeloma cells by ex-vivo culture and retroviral transduction of mobilized-blood CD34+ cells 68
The tyrosine phosphatase Shp2 interacts with NPM-ALK and regulates anaplastic lymphoma cell growth and migration 67
High-dose sequential chemoradiotherapy in multiple myeloma: residual tumor cells are detectable in bone marrow and peripheral blood cell harvests and after autografting. 66
Development of a consensus IgH quantitative assay for the detection of minimal residual disease in Chronic Lymphocytic Leukemia using 3’-minor groove binder probes. 66
The anaplastic lymphoma kinase as an oncogene in solid tumors 65
Liposomal doxorubicin reverses drug-resistance by inhibiting P-glycoprotein in human cancer cells 64
Inactivation of tumor suppressor genes, p53 and Rb1, in plasma cell dyscrasias. 62
PCR-detectable non-neoplastic Bcl-2/IgH rearrangements are common in normal subjects and cancer patients at diagnosis, but rare in subjects treated with chemotherapy. 61
Tyrosine phosphatases regulate resistance to ALK inhibitors in ALK+ anaplastic large cell lymphoma 61
Epitope mapping of spontaneous autoantibodies to anaplastic lymphoma kinase (ALK) in non-small cell lung cancer 60
LIGHT/TNFSF14 Promotes Osteolytic Bone Metastases in Non-small Cell Lung Cancer Patients 60
Advances in cancer immunology and cancer immunotherapy 59
The anaplastic lymphoma kinase in the pathogenesis of cancer 57
The battle against ALK resistance: successes and setbacks. 56
Targeting hif-1α regulatory pathways as a strategy to hamper tumor-microenvironment interactions in cll 56
Modulation of doxorubicin resistance by the glucose 6-phosphate dehydrogenase activity 51
RHO Family GTPases in the Biology of Lymphoma 51
Molecular and clinical remissions in multiple myeloma: role of autologous and allogeneic transplantation of hematopoietic cells. 50
Simple and Rapid InVivo Generation of Chromosomal Rearrangements using CRISPR/Cas9 Technology 48
Maspin and mammaglobin genes are specific markers for RT-PCR detection of minimal residual disease in patients with breast cancer 47
Liposome-encapsulated doxorubicin reverses drug resistance by inhibiting P-glycoprotein in human cancer cells. 46
Reduced-intensity conditioning followed by allografting of hematopoietic cells can produce clinical and molecular remissions in patients with poor-risk hematologic malignancies. 44
Modulation of doxorubicin resistance by the glucose 6-phosphate dehydrogenase activity 42
Modeling lung cancer evolution and preclinical response by orthotopic mouse allografts 40
Mutational activation of N- and K-ras oncogenes in plasma cell dyscrasias. 39
Molecular remission after myeloablative allogeneic stem cell transplantation predicts a better relapse-free survival in patients with multiple myeloma. 38
The Tyrosine Phosphatase SHP2 Interacts with NPM-ALK and Regulates Anaplastic Lymphoma Cell Growth and Migration. 38
Nonmyeloablative conditioning followed by hematopoietic cell allografting and donor lymphocyte infusions for patients with metastatic renal and breast cancer 37
Modulation of doxorubicin resistance by the glucose 6-phosphate dehydrogenase activity 34
Frequent mutations of FBXO11 highlight BCL6 as a therapeutic target in Burkitt lymphoma 34
Qualitative and quantitative polymerase chain reaction detection of the residual myeloma cell contamination after positive selection of CD34+ cells with small- and large-scale Miltenyi cell sorting system. 31
DNA repair mechanisms that promote insertion-deletion events during immunoglobulin gene diversification 21
Genomic Profiling Identifies Putative Pathogenic Alterations in NSCLC Brain Metastases 14
Review: biological implications of oncogenic rearrangements in non-small cell lung cancer 11
Regulation of CD45 phosphatase by oncogenic ALK in anaplastic large cell lymphoma 7
Targeting CCR7-PI3Kγ overcomes resistance to tyrosine kinase inhibitors in ALK-rearranged lymphoma 5
ALK inhibitors increase ALK expression and sensitize neuroblastoma cells to ALK.CAR-T cells 3
ALK peptide vaccination restores the immunogenicity of ALK-rearranged non-small cell lung cancer 3
Effects of blocking CD24 and CD47 'don't eat me' signals in combination with rituximab in mantle-cell lymphoma and chronic lymphocytic leukaemia 1
Totale 5.262
Categoria #
all - tutte 13.267
article - articoli 0
book - libri 0
conference - conferenze 498
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 13.765


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019179 0 0 0 0 0 0 0 0 18 39 88 34
2019/2020811 19 28 52 74 72 117 85 55 108 71 72 58
2020/2021662 42 48 62 27 67 31 50 32 77 99 53 74
2021/2022800 42 45 33 53 28 30 90 40 30 76 177 156
2022/20231.062 131 108 27 106 77 253 102 66 90 27 47 28
2023/2024398 69 82 37 33 46 80 6 38 7 0 0 0
Totale 5.262